A Novel Approach to Infantile Spasms

NCT03347526 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

394

Enrollment

OTHER

Sponsor class

Stopped Study on enrollment hold as a precaution per the pharmaceutical company.

Conditions

Infantile Spasm

Interventions

DRUG: Cosyntropin Injectable Suspension, 1 mg/mL
DRUG: Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
DRUG: Vigabatrin

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]